Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Clinical trial NCT05010681 · RECRUITING

Trial details

NCT number: NCT05010681
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma

Start date: 2021-08-24
Primary completion: 2025-08-20
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.